Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2024 Filed Mar 8, 2024 22:05 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 2,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006028 · form4.xml · derivative · entry 3 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,323 Underlying: Common Stock · 2,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F4 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:05 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Tax withholdingCommon Stock | 260 | $125.82 | $32,713.20 |
DisclosureSEC source: 0001062993-24-006028 · form4.xml · nonDerivative · entry 2 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,167 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:05 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionCommon Stock | 2,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006028 · form4.xml · nonDerivative · entry 1 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 191 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:05 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006027 · form4.xml · derivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,119 Underlying: Common Stock · 4,561 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:05 UTC |
Upadhyay SuketuExec. VP, CFO
|
Tax withholdingCommon Stock | 1,919 | $125.82 | $241,448.58 |
DisclosureSEC source: 0001062993-24-006027 · form4.xml · nonDerivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,764 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:05 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionCommon Stock | 4,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006027 · form4.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC |
Tornos IvanDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 10,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006025 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,536 Underlying: Common Stock · 10,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC |
Tornos IvanDirector · President & CEO
|
Tax withholdingCommon Stock | 5,642 | $125.82 | $709,876.44 |
DisclosureSEC source: 0001062993-24-006025 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,753 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC |
Tornos IvanDirector · President & CEO
|
Exercise / conversionCommon Stock | 10,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006025 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC |
Stellato Paul AVP, Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006024 · form4.xml · derivative · entry 3 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,215 Underlying: Common Stock · 609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F4 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC |
Stellato Paul AVP, Controller & CAO
|
Tax withholdingCommon Stock | 224 | $125.82 | $28,183.68 |
DisclosureSEC source: 0001062993-24-006024 · form4.xml · nonDerivative · entry 2 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 952 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC |
Stellato Paul AVP, Controller & CAO
|
Exercise / conversionCommon Stock | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006024 · form4.xml · nonDerivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 86 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006023 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 2,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Tax withholdingCommon Stock | 825 | $125.82 | $103,801.50 |
DisclosureSEC source: 0001062993-24-006023 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,221 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 2,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006023 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Ellingson RachelSVP & Chief Strategy Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006022 · form4.xml · derivative · entry 3 Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,837 Underlying: Common Stock · 1,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Ellingson RachelSVP & Chief Strategy Officer
|
Tax withholdingCommon Stock | 445 | $125.82 | $55,989.90 |
DisclosureSEC source: 0001062993-24-006022 · form4.xml · nonDerivative · entry 2 Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,846 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Ellingson RachelSVP & Chief Strategy Officer
|
Exercise / conversionCommon Stock | 1,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006022 · form4.xml · nonDerivative · entry 1 Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Bezjak MarkPresident, Americas
|
Exercise / conversionRestricted Stock Units · Derivative | 1,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006021 · form4.xml · derivative · entry 3 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,242 Underlying: Common Stock · 1,622 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Bezjak MarkPresident, Americas
|
Tax withholdingCommon Stock | 395 | $125.82 | $49,698.90 |
DisclosureSEC source: 0001062993-24-006021 · form4.xml · nonDerivative · entry 2 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,358 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Bezjak MarkPresident, Americas
|
Exercise / conversionCommon Stock | 1,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006021 · form4.xml · nonDerivative · entry 1 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006020 · form4.xml · derivative · entry 4 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,729 Underlying: Common Stock · 2,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F2 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006020 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 21:58 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005549 · form4.xml · derivative · entry 3 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 186 shares Expires 2024-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 21:58 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 46 | $124.28 | $5,716.88 |
DisclosureSEC source: 0001062993-24-005549 · form4.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,450 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 21:58 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005549 · form4.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:02 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 1,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005561 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,641 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:02 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Tax withholdingCommon Stock | 646 | $124.28 | $80,284.88 |
DisclosureSEC source: 0001062993-24-005561 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,951 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:02 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 1,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005561 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:59 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 2,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005553 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,052 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:59 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 2,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005553 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004690 · form4.xml · derivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,043 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC |
Upadhyay SuketuExec. VP, CFO
|
Tax withholdingCommon Stock | 2,091 | $128.80 | $269,320.80 |
DisclosureSEC source: 0001062993-24-004690 · form4.xml · nonDerivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,122 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionCommon Stock | 7,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004690 · form4.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 187 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC |
Tornos IvanDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004689 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,513 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC |
Tornos IvanDirector · President & CEO
|
Tax withholdingCommon Stock | 3,028 | $128.80 | $390,006.40 |
DisclosureSEC source: 0001062993-24-004689 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,125 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC |
Tornos IvanDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004689 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 121 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 4,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004688 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,580 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Tax withholdingCommon Stock | 1,769 | $128.80 | $227,847.20 |
DisclosureSEC source: 0001062993-24-004688 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,956 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 4,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004688 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC |
Ellingson RachelSVP & Chief Strategy Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004687 · form4.xml · derivative · entry 3 Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,762 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC |
Ellingson RachelSVP & Chief Strategy Officer
|
Tax withholdingCommon Stock | 588 | $128.80 | $75,734.40 |
DisclosureSEC source: 0001062993-24-004687 · form4.xml · nonDerivative · entry 2 Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,872 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC |
Ellingson RachelSVP & Chief Strategy Officer
|
Exercise / conversionCommon Stock | 1,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004687 · form4.xml · nonDerivative · entry 1 Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 195 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:56 UTC |
Bezjak MarkPresident, Americas
|
Exercise / conversionRestricted Stock Units · Derivative | 1,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004685 · form4.xml · derivative · entry 3 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,528 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:56 UTC |
Bezjak MarkPresident, Americas
|
Tax withholdingCommon Stock | 404 | $128.80 | $52,035.20 |
DisclosureSEC source: 0001062993-24-004685 · form4.xml · nonDerivative · entry 2 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,131 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:56 UTC |
Bezjak MarkPresident, Americas
|
Exercise / conversionCommon Stock | 1,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004685 · form4.xml · nonDerivative · entry 1 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 25 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:56 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004686 · form4.xml · derivative · entry 3 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,294 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:56 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 351 | $128.80 | $45,208.80 |
DisclosureSEC source: 0001062993-24-004686 · form4.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,310 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:56 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004686 · form4.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 3 shares acquired pursuant to dividend reinvestment through February 1, 2024. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:55 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 5,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004684 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,047 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.